On March 21, 2023, Dr. Jay McLaughlin, Ph.D., was invited to the Washington University School of Medicine in St. Louis, MO to give a presentation, “Investigating the sigma-1 receptor as a potential target for treating chronic pain or psychostimulant use disorder.”